Clinical and Translational Science Award
临床和转化科学奖
基本信息
- 批准号:10665627
- 负责人:
- 金额:$ 371.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAutomobile DrivingBasic ScienceChicagoClinicalClinical ResearchClinical SciencesClinical and Translational Science AwardsCollaborationsCommunitiesCommunity HealthComplexDataData SourcesDevelopmentDisciplineDissemination and ImplementationEducationEthnic OriginEvaluationFoundationsFundingGoalsHealthHealth PersonnelHealth SciencesIllinoisIndividualIndustryInformaticsInstitutionLongevityMethodsMinority GroupsMissionModelingMovementOutcomePatientsPersonsPoliciesPolicy MakerPopulationPopulation HeterogeneityPositioning AttributePostdoctoral FellowProcessReproducibilityResearchResourcesScienceScientistSiteSpecial PopulationSystemTrainingTraining ProgramsTranslational ResearchTranslationsUnderserved PopulationUnited States National Institutes of HealthUniversitiesVulnerable PopulationsWorkforce Developmentcatalystclinical centerclinical translationcollegecommunity engaged researchcommunity engagementgraduate studentimplementation scienceimprovedinformatics infrastructureinnovationmembermethod developmentmulti-site trialmultidisciplinarymultimodal datapopulation healthprogramsrecruitsocial health determinantssuccesstranslational barriertranslational pipeline
项目摘要
The University of Illinois at Chicago (UIC) Center for Clinical and Translational Science (CCTS) seeks to catalyze
translational research, locally and nationally, as part of a national network to improve individual and population
health. Since our initial funding by the NIH in 2009, the CCTS has been a catalyst for mobilizing institutional
support and resources to enhance clinical translational research and expand multidisciplinary training programs
to increase workforce diversity and promote team science. The overarching goal—and driving focus—of the
CCTS is to improve population health, particularly among minorities and underserved populations. Our high-
quality multidisciplinary clinical and translational research, spanning T1-T4 and paired with strengths in
community engagement and implementation science and appreciation for the social determinants of health, help
to accelerate discoveries into practice and policy. Building on our organizational foundation and record of
success, the UIC CCTS is well-positioned to make substantial contributions by collaborating with other hubs,
supporting national CTSA activities, and making unique contributions to community-engaged research with
vulnerable and underserved populations. As we move forward, we will continue to develop streamlined
processes and resources to facilitate research processes and aid collaboration; to develop and prepare a
translational science workforce that is multidisciplinary and comfortable in team science; to use innovative
informatics solutions to advance translational research; and to have ready-to-deploy systems to respond rapidly
to innovative, collaborative projects. We will achieve our objectives through the following global specific aims:
1) Develop a skillful and diverse translational workforce to conduct multidisciplinary team science and advance
translation of discoveries; 2) Engage a broad range of stakeholders in clinical translational research, including
patients, community leaders, health care providers and clinicians, industry and policy makers; and further support
collaboration among the CTSA hubs; 3) Integrate, support, and accelerate clinical translational research across
the full translational spectrum with multiple disciplines and with diverse populations across the lifespan; 4)
Promote advances in study and development of methods and processes of conducting translational science that
will enable advances in translation; and 5) Support the use and advance of innovative informatics solutions to
advance translational research and to help train the CTSA workforce. These aims will direct our course over the
next five years, as we further evolve the clinical and translational enterprise, contribute to the CTSA network,
and advance the health of the people of Illinois and the nation.
伊利诺伊大学芝加哥分校 (UIC) 临床和转化科学中心 (CCTS) 致力于促进
地方和国家的转化研究,作为改善个人和人口的国家网络的一部分
健康。自 2009 年 NIH 首次资助以来,CCTS 一直是动员机构的催化剂
支持和资源,以加强临床转化研究并扩大多学科培训计划
增加劳动力多样性并促进团队科学。的总体目标和驱动重点
CCTS 旨在改善人口健康,特别是少数族裔和服务不足人群的健康。我们的高
高质量的多学科临床和转化研究,跨越 T1-T4,并与以下方面的优势相结合
社区参与和实施科学以及对健康的社会决定因素的认识,帮助
加速将发现转化为实践和政策。以我们的组织基础和记录为基础
UIC CCTS 的成功,使其能够通过与其他中心的合作做出重大贡献,
支持国家 CTSA 活动,并为社区参与的研究做出独特贡献
弱势和服务不足的人群。在我们前进的过程中,我们将继续开发精简的
促进研究进程和援助协作的流程和资源;制定并准备一个
多学科且擅长团队科学的转化科学劳动力;使用创新的
推进转化研究的信息学解决方案;并拥有可立即部署的系统以快速响应
创新的协作项目。我们将通过以下全球具体目标来实现我们的目标:
1) 培养一支熟练且多元化的翻译队伍,以进行多学科团队科学和进步
翻译发现; 2) 让广泛的利益相关者参与临床转化研究,包括
患者、社区领袖、医疗保健提供者和临床医生、行业和政策制定者;以及进一步的支持
CTSA 中心之间的协作; 3) 整合、支持和加速跨领域的临床转化研究
跨学科、跨生命周期的不同人群的完整翻译范围; 4)
促进转化科学方法和过程的研究和开发进步,
将促进翻译的进步; 5) 支持创新信息学解决方案的使用和推进
推进转化研究并帮助培训 CTSA 员工队伍。这些目标将指导我们的前进方向
未来五年,随着我们进一步发展临床和转化企业,为 CTSA 网络做出贡献,
促进伊利诺伊州人民和国家的健康。
项目成果
期刊论文数量(375)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.
- DOI:10.1016/j.virol.2021.11.007
- 发表时间:2022-01
- 期刊:
- 影响因子:3.7
- 作者:Oropeza CE;Ondracek CR;Tarnow G;Maienschein-Cline M;Green SJ;McLachlan A
- 通讯作者:McLachlan A
Texture analysis of placental MRI: can it aid in the prenatal diagnosis of placenta accreta spectrum?
- DOI:10.1007/s00261-019-02104-1
- 发表时间:2019-09-01
- 期刊:
- 影响因子:2.4
- 作者:Chen, Eric;Mar, Winnie A.;Cai, Kejia
- 通讯作者:Cai, Kejia
Implementing an Electronic Patient-Reported Outcome and Decision Support Tool in Early Intervention.
- DOI:10.1055/s-0042-1760631
- 发表时间:2023-01
- 期刊:
- 影响因子:2.9
- 作者:Rizk, Sabrin;Kaelin, Vera C.;Sim, Julia Gabrielle C.;Murphy, Natalie J.;McManus, Beth M.;Leland, Natalie E.;Stoffel, Ashley;James, Lesly;Barnekow, Kris;Papautsky, Elizabeth Lerner;Khetani, Mary A.
- 通讯作者:Khetani, Mary A.
The interplay of stress and electrocortical reactivity to reward in the prospective prediction of depression symptoms during COVID-19.
- DOI:10.1016/j.jpsychires.2021.05.034
- 发表时间:2021-08
- 期刊:
- 影响因子:4.8
- 作者:Feurer C;Granros M;Calentino AE;Suor JH;Patel K;Burkhouse KL
- 通讯作者:Burkhouse KL
Diabetes multimorbidity combinations and disability in the Mexican Health and Aging Study, 2012-2015.
- DOI:10.1016/j.archger.2020.104292
- 发表时间:2021-03
- 期刊:
- 影响因子:4
- 作者:McClellan SP;Haque K;García-Peña C
- 通讯作者:García-Peña C
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robin J. Mermelstein其他文献
Changing knowledge and attitudes about skin cancer risk factors in adolescents.
改变青少年对皮肤癌危险因素的认识和态度。
- DOI:
10.1037//0278-6133.11.6.371 - 发表时间:
1992 - 期刊:
- 影响因子:0
- 作者:
Robin J. Mermelstein;L. A. Riesenberg - 通讯作者:
L. A. Riesenberg
Semantic congruity and expectancy in symbolic judgments.
符号判断中的语义一致性和期望。
- DOI:
10.1037/0096-1523.9.4.560 - 发表时间:
1983 - 期刊:
- 影响因子:0
- 作者:
William P. Banks;Hedy White;William Sturgill;Robin J. Mermelstein - 通讯作者:
Robin J. Mermelstein
Erratum: Do as i say, not as i do: Does it work for tobacco use prevention? (Archives of Pediatrics and Adolescent Medicine (January 2006) 160 (102-103))
勘误表:按我说的做,而不是照我做的做:它对预防烟草使用有效吗?
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Susan J. Curry;Robin J. Mermelstein - 通讯作者:
Robin J. Mermelstein
Explanations of ethnic and gender differences in youth smoking: a multi-site, qualitative investigation. The Tobacco Control Network Writing Group.
青少年吸烟的种族和性别差异的解释:多地点定性调查。
- DOI:
10.1080/14622299050011661 - 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Robin J. Mermelstein - 通讯作者:
Robin J. Mermelstein
Shared and distinct neural mechanisms of inhibitory control in individuals with a history of a substance use disorder and depression
- DOI:
10.1016/j.drugalcdep.2015.07.1055 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:
- 作者:
Natania A. Crane;Laura Gabriel;Kortni K. Meyers;Anne L. Weldon;Michelle T. Kassel;Robin J. Mermelstein;Jon-Kar Zubieta;Scott A. Langenecker - 通讯作者:
Scott A. Langenecker
Robin J. Mermelstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robin J. Mermelstein', 18)}}的其他基金
Context, Subjective and Cognitive Experiences with Patterns of Tobacco and Cannabis Co-Use in Young Adults
年轻人烟草和大麻共同使用模式的背景、主观和认知体验
- 批准号:
10602422 - 财政年份:2020
- 资助金额:
$ 371.04万 - 项目类别:
Context, Subjective and Cognitive Experiences with Patterns of Tobacco and Cannabis Co-Use in Young Adults
年轻人烟草和大麻共同使用模式的背景、主观和认知体验
- 批准号:
10378068 - 财政年份:2020
- 资助金额:
$ 371.04万 - 项目类别:
Context, Subjective and Cognitive Experiences with Patterns of Tobacco and Cannabis Co-Use in Young Adults
年轻人烟草和大麻共同使用模式的背景、主观和认知体验
- 批准号:
10205015 - 财政年份:2020
- 资助金额:
$ 371.04万 - 项目类别:
Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)
烟草监管科学分析、科学、增强和物流协调中心 (CASEL) (U54)
- 批准号:
10477396 - 财政年份:2018
- 资助金额:
$ 371.04万 - 项目类别:
Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science
烟草监管科学分析、科学、增强和物流协调中心 (CASEL)
- 批准号:
10662756 - 财政年份:2018
- 资助金额:
$ 371.04万 - 项目类别:
Center for Coordination of Analytics, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54)
烟草监管科学分析、科学、增强和物流协调中心 (CASEL) (U54)
- 批准号:
10245072 - 财政年份:2018
- 资助金额:
$ 371.04万 - 项目类别:
Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes
可燃卷烟吸烟者转向标准化研究电子烟的预测因素和后果
- 批准号:
10811935 - 财政年份:2017
- 资助金额:
$ 371.04万 - 项目类别:
Strengthening Stakeholder Engagement in Human Research Protections.
加强利益相关者对人类研究保护的参与。
- 批准号:
10363791 - 财政年份:2016
- 资助金额:
$ 371.04万 - 项目类别:
Quality Assurance and Quality Control Administrative Supplement
质量保证和质量控制行政补充
- 批准号:
10382106 - 财政年份:2016
- 资助金额:
$ 371.04万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 371.04万 - 项目类别:
Research Grant














{{item.name}}会员




